These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90. Brachytherapy as a treatment option for prostate cancer: overview and nursing considerations. Brumm J Proc (Bayl Univ Med Cent); 2000 Jul; 13(3):227-9. PubMed ID: 16389386 [No Abstract] [Full Text] [Related]
91. Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy. Slawin KM; Diblasio CJ; Kattan MW Rev Urol; 2004; 6 Suppl 4(Suppl 4):S3-8. PubMed ID: 16985868 [TBL] [Abstract][Full Text] [Related]
92. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. Stokes SH Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):129-36. PubMed ID: 10758314 [TBL] [Abstract][Full Text] [Related]
93. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Ragde H; Korb LJ; Elgamal AA; Grado GL; Nadir BS Cancer; 2000 Jul; 89(1):135-41. PubMed ID: 10897010 [TBL] [Abstract][Full Text] [Related]
94. Does brachytherapy have a role in the treatment of prostate cancer? Grimm PD; Blasko JC; Ragde H; Sylvester J; Clarke D Hematol Oncol Clin North Am; 1996 Jun; 10(3):653-73. PubMed ID: 8773503 [TBL] [Abstract][Full Text] [Related]